Trial
NCT03209869
Treatment of Relapsed or Refractory Neuroblastoma and Osteosarcoma With Expanded Haploidentical NK Cells and Hu14.18-IL2
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Wisconsin, Madison
Collaborators
National Cancer Institute (NCI); Solving Kids' Cancer; Midwest Athletes Against Childhood Cancer, Inc. (MACC Fund); Wade's Army; The Catherine Elizabeth Blair Memorial Foundation / GWCF
Condition
Neuroblastoma
Intervention
Ex vivo Expanded and Activated Haploidentical Donor NK Cells
Why stopped
resources limited due to COVID-19
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-09-13